Back to LINCOLN
Clear

Board Meetings for LINCOLN

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
LINCOLNLincoln Pharmaceuticals Limited08 Aug 2024LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business.Board Meeting Intimation
PDF
LINCOLNLincoln Pharmaceuticals Limited16 May 2024Financial Results/DividendTo consider and approve the Audited financial results (Standalone & Consolidated)of the Company for the Quarter and Year ended March 31, 2024 and recommendation of dividend if any.
PDF
LINCOLNLincoln Pharmaceuticals Limited16 May 2024LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 16-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.Board Meeting Intimation
PDF
LINCOLNLincoln Pharmaceuticals Limited08 Feb 2024Financial ResultsIntimation of Board meeting to consider and approve the unaudited (standalone & Consolidated) financial results for the period ended December 31, 2023.
PDF
LINCOLNLincoln Pharmaceuticals Limited08 Feb 2024LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .Board Meeting Intimation
PDF
LINCOLNLincoln Pharmaceuticals Limited02 Nov 2023LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 .Board Meeting Intimation
PDF
LINCOLNLincoln Pharmaceuticals Limited02 Nov 2023Financial ResultsIntimation of Board Meeting to consider and approve the financial results for the period ended September 30, 2023
PDF
LINCOLNLincoln Pharmaceuticals Limited10 Aug 2023Financial ResultsTo Consider and Approve the Un-Audited Financial Results for the Quarter ended on June 30, 2023.
PDF
LINCOLNLincoln Pharmaceuticals Limited10 Aug 2023LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business.Board Meeting Intimation
PDF
LINCOLNLincoln Pharmaceuticals Limited25 May 2023Financial Results/DividendBoard Meeting Intimation Inter-Alia To Consider And Approve The Audited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31, 2023.
PDF
LINCOLNLincoln Pharmaceuticals Limited25 May 2023LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 25-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend.Board Meeting Intimation
PDF
LINCOLNLincoln Pharmaceuticals Limited09 Feb 2023Financial ResultsTo consider and approve the financial results for the period ended December 31, 2022
PDF
LINCOLNLincoln Pharmaceuticals Limited10 Nov 2022Financial resultsLincoln Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2022 to consider financial statements for the period ended September 2022
PDF
LINCOLNLincoln Pharmaceuticals Limited09 Aug 2022Financial resultsLincoln Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 09-Aug-2022 to consider financial statements for the period ended June 2022 and other matters
PDF
LINCOLNLincoln Pharmaceuticals Limited19 May 2022Financial resultsLincoln Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 19-May-2022 to consider financial statements for the period ended March 2022
PDF
Showing page 2 of 5 (61 total items)
PreviousNext